The lost cells and tissues by the repeated chemotherapy and radiations can be easily replaced in cancer patients. It helps in the better understanding of genetic diseases too. The clinical application of this property has had much interest to the biomedical researchers in the recent years. There had been a number of researches confirming the clinical application of cloning. Stojanoski et al, (2009, 71-84) has opined that stem cells that are taken from the peripheral blood, bone marrow and umbilical cord can be cloned to treat heametological malignancies. The same study has also revealed the possibility of utilizing stem cell clones in the treatment of non heametological diseases, heart problems, diseases pertaining to the immune system and degenerative disorders (Stojanoski et al, 2009, 71-84). Thus the study confirms the role of cloning in evolving with potential solutions to a number of detrimental diseases. Thus the importance of cloning in relation to its clinical application can be considered of due relevance. Stojanoski et al, (2009, 71-84) has further confirmed this point by citing examples from the successful case studies done at the Hematology Department, Skopje and the Skopje Cardiology clinic. Acute Myocardial infraction has been reported by the study as treated effectively using clones of stem cells from bone marrow Stojanoski et al, (2009, 71-84) The study has urged further research in the area so that it can be developed as a confirmed therapeutic solution.